Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series a…

[Read more →]

Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis.
Antimicrob Agents Chemother. 2011 Oct 17;
Authors: Retamar P, Portillo MM, López-Prieto MD, R…

[Read more →]

Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system.
Antimicrob Agents Chemother. 2011 Jul;55(7):3485-90
Authors: Tu…

[Read more →]

Procalcitonin-guided therapy in respiratory tract infections: a meta-analysis and systematic review.
Antimicrob Agents Chemother. 2011 Sep 26;
Authors: Li H, Luo YF, Blackwell TS, Xie CM
Abstract
Circulating pr…

[Read more →]

The Relationship Between Vancomycin Trough Concentrations and Nephrotoxicty: A Prospective, Multi-center Trial.
Antimicrob Agents Chemother. 2011 Sep 26;
Authors: Bosso JA, Nappi J, Rudisill C, Wellein M, Bookstaver PB, Swindl…

[Read more →]

Dose of Trimethoprim-Sulfamethoxazole to Treat Skin and Skin Structure Infections Caused by Methicillin Resistant Staphylococcus aureus.
Antimicrob Agents Chemother. 2011 Sep 19;
Authors: Cadena J, Nair S, Henao-Martinez AF, J…

[Read more →]

Carbapenems: past, present, and future.
Antimicrob Agents Chemother. 2011 Aug 22;
Authors: Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA
Abstract
In this review, we summarize the current “state of the ar…

[Read more →]

Prediction of Failure in Vancomycin-Treated Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Clinically Useful Risk Stratification Tool.
Antimicrob Agents Chemother. 2011 Aug 8;
Authors: Moore CL, Lu M, Che…

[Read more →]

Comparison of single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection: A phase III randomized, double-blind study.
Antimicrob Agents Chemother. 2011 Aug 8;
Authors: Kohno S, …

[Read more →]

Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?
Antimicrob Agents Chemother. 2011 Aug 8;
Authors: Lee S, Choe PG, Song KH, Park SW, Kim HB, Kim NJ, Kim EC, Park WB,…

[Read more →]

Outcomes of Moderate-to-Severe Pneumocystis Pneumonia Treated with Adjunctive Steroid in Non-HIV-Infected Patients.
Antimicrob Agents Chemother. 2011 Jul 25;
Authors: Moon SM, Kim T, Sung H, Kim MN, Kim SH, Choi SH, Jeong JY, …

[Read more →]

Susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada.
Antimicrob Agents Chemother. 2011 May 31;
Authors: Patel SN, McGeer A, Melano R, Tyrrell GJ, Green K, Pillai DR, Low DE,
Ciprofloxacin, the fi…

[Read more →]

Antimicrobial Resistance in Urinary Tract Pathogens in Canada from 2007 to 2009: CANWARD Surveillance Study.
Antimicrob Agents Chemother. 2011 May 2;
Authors: Karlowsky JA, Lagacé-Wiens PR, Simner PJ, Decorby MR, Adam HJ, Wal…

[Read more →]

Intravenous peramivir for treatment of influenza A and B infection in high-risk patients.
Antimicrob Agents Chemother. 2011 Apr 4;
Authors: Kohno S, Kida H, Mizuguchi M, Hirotsu N, Ishida T, Kadota J, Shimada J,
Infl…

[Read more →]

Optimization of Aminoglycoside Therapy.
Antimicrob Agents Chemother. 2011 Mar 14;
Authors: Drusano GL, Louie A
Aminoglycosides are experiencing a resurgence in use because of the spread of multi-resistant Gram-negative…

[Read more →]